The Significance of Bayesian Pharmacokinetics in Dosing for Critically Ill Patients: A Primer for Clinicians Using Vancomycin as an Example
Antibiotic use is becoming increasingly challenging with the emergence of multidrug-resistant organisms. Pharmacokinetic (PK) alterations result from complex pathophysiologic changes in some patient populations, particularly those with critical illness. Therefore, antibiotic dose individualization i...
Saved in:
Main Authors: | Faris S. Alnezary (Author), Masaad Saeed Almutairi (Author), Anne J. Gonzales-Luna (Author), Abrar K. Thabit (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessing Galleria mellonella as a preliminary model for systemic Staphylococcus aureus infection: Evaluating the efficacy and impact of vancomycin and Nigella sativa oil on gut microbiota
by: Faris S. Alnezary, et al.
Published: (2023) -
Acute kidney injury associated with piperacillin-tazobactam versus other antibiotics combined with vancomycin in critically ill patients: A retrospective cohort study
by: Masaad S. Almutairi, et al.
Published: (2023) -
Vancomycin population pharmacokinetic modeling in children using Bayesian estimation and a Non Parametric Approach
by: Anna Luísa Oliveira Silveira, et al.
Published: (2022) -
Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model‐informed precision dosing trial simulations
by: Abdullah Aljutayli, et al.
Published: (2022) -
Altered Pharmacokinetics Parameters of Vancomycin in Patients with Hematological Malignancy with Febrile Neutropenia, a Bayesian Software Estimation
by: Abdullah M. Alzahrani, et al.
Published: (2023)